Amex Resumed Cel: SCI CORP ORD
Brief: Cel-Sci’S Multikine Immunotherapy Produces Significant 14.1% 5-Year Survival Benefit (62.7% Versus 48.6%) In The Group Receiving Surgery Plus Radiotherapy
AMEX HALT ADDITIONAL INFORMATION LAST 22.890000
Amex Resumed Cel: SCI CORP ORD
Brief: CEL-SCI Increases Previously Announced Bought Deal To $31.7 Mln
Brief: CEL-SCI Announces Bought Deal Offering
Brief: CEL-SCI Reports Q2 Loss Per Share Of $0.28
Factbox: Mortgage dealers hop on Reddit-fueled short squeeze bandwagon
Brief: CEL-SCI Corporation Reports First Quarter Fiscal 2021 Financial Results
Factbox: The stocks of the Reddit-fueled trading frenzy
Factbox: The stocks of the Reddit-fueled trading frenzy
Amex Resumed Cel: SCI CORP ORD
AMEX HALT ADDITIONAL INFORMATION LAST 25.570000
Factbox: Stocks shunned by Wall Street surge as 'GameStop Effect' snowballs
Amex Resumed Cel: SCI CORP ORD
AMEX HALT ADDITIONAL INFORMATION LAST 34.150000
Amex Resumed Cel: SCI CORP ORD
AMEX HALT ADDITIONAL INFORMATION LAST 32.030000
Amex Resumed Cel: SCI CORP ORD